Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
77.40
-0.19 (-0.24%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Moderna Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
99
100
Next >
3 Healthcare Stocks Short Sellers Are Prescribing for Trouble
April 05, 2024
The healthcare industry is one of the most potent yet also one of the most competitive. This has short sellers out for blood.
Via
InvestorPlace
Moderna's Vaccines Day 2024: A Glimpse into the Future of Infectious Disease Prevention
April 05, 2024
Moderna, Inc. (NASDAQ: MRNA) recently hosted its fourth annual Vaccines Day, offering a deep dive into the company's expanding infectious disease vaccines portfolio.
Via
Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in April 2024
April 05, 2024
The most undervalued biotech stocks to buy in April are intriguing value options with mature biotech plays that boast impressive pipelines.
Via
InvestorPlace
Arbutus Vs. Moderna Patent Dispute Over Covid-19 Vaccine Gets Response From Judge
April 04, 2024
Delaware Judge favors Arbutus and Genevant Sciences in their patent dispute with Moderna over COVID-19 vaccine technology.
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Moderna Shares Slip Over Covid Vaccine Patent Dispute, But Chart Signals Potential Rebound Ahead
April 04, 2024
Moderna stock falls 2.32% due to patent infringement suit. However, some investors see this as an opportunity to enter or average out. Golden Cross formation also offers hope for future growth.
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
2 Stocks Down 30% and 27% to Buy and Hold
April 01, 2024
Look beyond these companies' challenges.
Via
The Motley Fool
Moderna Stock: Buy, Sell, or Hold?
April 01, 2024
Moderna is more than its COVID-19 vaccine, but risks for investors still exist.
Via
The Motley Fool
Exposures
COVID-19
Better Recovery Story Buy: Pfizer vs Moderna
April 01, 2024
Pfizer and Moderna each have slipped about 30% over the past year.
Via
The Motley Fool
Arbutus Stock Soars 20% As It Heads To Trial With Moderna In Covid Vaccine Patent Claim
April 03, 2024
Arbutus Biopharma soared more than 20% on Wednesday, April 3, after the company received permission to pursue a claim against Moderna in court.
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
10 Health Care Stocks Whale Activity In Today's Session
April 03, 2024
Via
Benzinga
Pharma's Post-Pandemic Story To Unlock A Cancer-Free Era
April 02, 2024
Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) did not only earn billions of dollars from their COVID-19 leading products but also rose to fame for saving the world from an unforeseen pandemic.
Via
Benzinga
Exposures
COVID-19
Is Moderna Stock Going to $214? 1 Wall Street Analyst Thinks So.
April 01, 2024
Moderna, famous for its coronavirus vaccine, is only at the start of a trip skyward, a market professional believes.
Via
The Motley Fool
Exposures
COVID-19
10 Health Care Stocks With Whale Alerts In Today's Session
March 28, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Moderna Through 5 Analysts
March 28, 2024
Via
Benzinga
Here's How Much $100 Invested In Moderna 5 Years Ago Would Be Worth Today
March 25, 2024
Via
Benzinga
Behind the Scenes of Moderna's Latest Options Trends
March 22, 2024
Via
Benzinga
3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition
March 28, 2024
Discover these three biotech stocks set for major gains with groundbreaking health solutions. Invest in the future of medicine.
Via
InvestorPlace
Bull Market Buys: 3 Dividend Stocks to Own for the Long Run
March 28, 2024
Invest in stability, dividends, and growth with these three accomplished real estate operators.
Via
The Motley Fool
Better Cathie Wood Stock: Moderna vs. Intellia
March 28, 2024
Moderna and Intellia have declined in the double digits over the past year.
Via
The Motley Fool
3 Biotech Stocks to Buy on the Dip: March 2024
March 27, 2024
Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three.
Via
InvestorPlace
What's Going On With Moderna Stock Wednesday?
March 27, 2024
Moderna shares are trading higher Wednesday after the company announced that MRNA-1283 met the primary endpoints in its Phase 3 clinical trial. Additionally, Blackstone Life Sciences announced an...
Via
Benzinga
Cathie Wood's Ark Invest Continues To Double Down On Moderna, Sells Nvidia Shares
March 26, 2024
Via
Benzinga
Moderna's Next Gen COVID Vaccine Meets Primary Goal In Late-Stage Trial
March 26, 2024
Moderna announces Phase 3 trial results for mRNA-1283, its next-gen COVID-19 vaccine. A higher immune response was observed compared to mRNA-1273.222. Detailed data will be unveiled at upcoming...
Via
Benzinga
Exposures
COVID-19
Cathie Wood's Ark Ups Tesla Bet With $28M Stock Buy Amid Rebound, Also Loads Up On This Online Game Platform
March 26, 2024
Through its two ETFs, Ark Innovation ETF and ARK Next Generation Internet ETF, Ark bought 163,421 Tesla shares.
Via
Benzinga
Topics
ETFs
Two Hot AI Stocks Lead S&P 500 Monday
March 25, 2024
Super Micro and Micron , two big winners in 2024, led the way Monday.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
A Bull Market Is Here: 2 Magnificent Stocks Down 30% or More to Buy Right Now
March 23, 2024
These stocks share several things in common.
Via
The Motley Fool
Artificial Intelligence (AI) in Healthcare: 2 Top Stock Picks
March 23, 2024
These particular healthcare stocks are dirt cheap now considering their AI potential.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Is Cathie Wood Buying The Rumor? Ark More Than Doubles Stake In This COVID-19 Vaccine Maker Ahead Of Flurry Of Catalysts
March 21, 2024
Ark, through its flagship Ark Innovation ETF and Ark Genomic Revolution ETF, has been brisk with its acquisition of Moderna shares in March.
Via
Benzinga
Topics
ETFs
Exposures
COVID-19
Cathie Wood's Ark Invest Sells Another Tranche Of Block Shares, Even As Bitcoin Price Stages A Recovery
March 20, 2024
On Wednesday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Block Inc (NYSE:SQ) amidst Bitcoin (CRYPTO: BTC) prices recovering.
Via
Benzinga
Why Moderna Shares Are Falling
March 20, 2024
Moderna shares are trading lower by 2.7% during Wednesday's session. The stock is falling in possible sympathy with BioNTech, which reported worse than expected fourth-quarter earnings.
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.